Dr Reddy's Plan B for Nexium generic in play; appetite for M&A too
This article was originally published in Scrip
Dr Reddy's Laboratories appears to have progressed its Plan B - essentially a site transfer - to hang on to the generic Nexium (esomeprazole magnesium) opportunity.
You may also be interested in...
Scrip traces some of the prominent changes in the corner office at front-line, family-owned Indian firms Cipla and Dr Reddy’s in the decade gone by.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.